Contents
Download PDF
pdf Download XML
358 Views
109 Downloads
Share this article
Research Article | Volume 13 Issue:4 (, 2023) | Pages 1355 - 1356
Dyke-Davidoff-Masson syndrome is a rare syndrome with characteristic cerebral hemiatrophy/hypoplasia, contralateral hemiparesis, seizures, and compensatory osseous hypertrophy
1
MD Paediatrics, Senior Resident, Department of Paediatrics, Government Medical College, Patiala
Under a Creative Commons license
Open Access
Received
Oct. 1, 2023
Revised
Nov. 7, 2023
Accepted
Dec. 1, 2023
Published
Dec. 26, 2023
Abstract

Background: Dyke-Davidoff-Masson syndrome is a rare condition resulting from brain injury due to a multitude of causes; especially in early life. Characteristics include cerebral hemiatrophy/hypoplasia, contralateral hemiparesis, seizures, and compensatory osseous hypertrophy. Case presentation: We present a case of a 14-year-old girl who initially presented with left sided hemiparesis. Computed tomography (CT) showed evidence of right cerebral atrophy. Workup for paediatric stroke was negative. Upon further evaluation by Neuroradiology, features suggesting Dyke-Davidoff-Masson syndrome were confirmed. Patient has been under Neurology follow up since. Conclusions: Due to its rarity, Dyke-Davidoff-Masson syndrome may easily be missed by the majority of treating clinicians. Knowledge of its features on imaging enables timely and accurate diagnosis – allowing appropriate management.

Keywords
Recommended Articles
Research Article
Correlation Between Electrographic Changes and Troponin I Levels in Patients Presenting with Chest Pain in Emergency Medicine Department of Tertiary Care Centre
...
Published: 16/11/2025
Download PDF
Research Article
Assessing the Relationship Between Thiazide Use and Syncope Or Fall in Hypertensive Indian Subjects Admitted to the Tertiary Care Hospital
...
Published: 24/05/2025
Download PDF
Research Article
Evaluation of Matrix Metalloproteinases-3 As A Possible Biomarker For Oral Sub Mucous Fibrosis
Published: 24/11/2025
Download PDF
Short Commentary Article
Commentary: Crystalline Precision: The Clinical Impact of Co-Crystal Formulation Differences in Sacubitril/Valsartan for HFrEF
Published: 22/11/2025
Download PDF
Chat on WhatsApp
Copyright © EJCM Publisher. All Rights Reserved.